Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin

被引:38
作者
Brouwers, E. E. M. [1 ]
Tibben, M. M. [1 ]
Pluim, D. [2 ]
Rosing, H. [1 ]
Boot, H. [3 ]
Cats, A. [3 ]
Schellens, J. H. M. [3 ,4 ]
Beijnen, J. H. [1 ,4 ]
机构
[1] Netherlands Canc Inst, Dept Pharm & Pharmacol, Slotervaart Hosp, NL-1066 EC Amsterdam, Netherlands
[2] Netherlands Canc Inst, Dept Expt Therapy, Antoni Van Leeuwenhoek Hosp, NL-1066 CX Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Med Oncol, Antoni Van Leeuwenhoek Hosp, NL-1066 CX Amsterdam, Netherlands
[4] Univ Utrecht, Beta Fac, Dept Pharmaceut Sci, Div Biomed Anal,Sect Drug Toxicol, NL-3508 TB Utrecht, Netherlands
关键词
ICP-MS; platinum; DNA adducts; peripheral blood mononuclear cells; tissue;
D O I
10.1007/s00216-008-2034-8
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We present a highly sensitive method for the determination of platinum (Pt) in DNA extracts of peripheral blood mononuclear cells (PBMCs) and tissue samples from patients treated with cisplatin. The method is based on the measurement of Pt by inductively coupled plasma mass spectrometry (ICP-MS) and allows quantification of Pt-DNA adducts in PBMCs isolated from 10 mL blood and 1 mg tissue. The lower limit of quantification is 0.75 pg Pt or 7.5 fg Pt mu g(-1) DNA when using 100 mu g DNA. The method proved to be accurate and precise. The results obtained using the ICP-MS method were in good agreement with results from the alternative (32)P-postlabelling assay. The ICP-MS method was, however, more sensitive and proved to be less laborious. The advantages of the presented ICP-MS technique were demonstrated by the analysis of PBMCs, normal gastric tissue, and gastric tumour tissue of patients treated with cisplatin.
引用
收藏
页码:577 / 585
页数:9
相关论文
共 20 条
[1]
Azim-Araghi A, 2003, PLASMA SOURCE MASS SPECTROMETRY: APPLICATIONS AND EMERGING TECHNOLOGIES, P66
[2]
Determination of platinum in human subcellular microsamples by inductively coupled plasma mass spectrometry [J].
Bjorn, Erik ;
Nygren, Yvonne ;
Nguyen, Tam Trinh Thi Nhu ;
Ericson, Christer ;
Nojd, Mikael ;
Naredi, Peter .
ANALYTICAL BIOCHEMISTRY, 2007, 363 (01) :135-142
[3]
Bonetti A, 1996, CLIN CANCER RES, V2, P1829
[4]
Modification and uptake of a cisplatin carbonato complex by Jurkat cells [J].
Centerwall, Corey R. ;
Tacka, Kirk A. ;
Kerwood, Deborah J. ;
Goodisman, Jerry ;
Toms, Bonnie B. ;
Dubowy, Ronald L. ;
Dabrowiak, James C. .
MOLECULAR PHARMACOLOGY, 2006, 70 (01) :348-355
[5]
A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk acute leukemia [J].
Cooper, BW ;
Veal, GJ ;
Radivoyevitch, T ;
Tilby, MJ ;
Meyerson, HJ ;
Lazarus, HM ;
Koc, ON ;
Creger, RJ ;
Pearson, G ;
Nowell, GM ;
Gosky, D ;
Ingalls, ST ;
Hoppel, CL ;
Gerson, SL .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6830-6839
[6]
FICHTINGERSCHEPMAN AMJ, 1990, CANCER RES, V50, P7887
[7]
Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT) [J].
Hoebers, Frank J. P. ;
Pluim, Dick ;
Verheij, Marcel ;
Balm, Alfons J. M. ;
Bartelink, Harry ;
Schellens, Jan H. M. ;
Begg, Adrian C. .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) :750-756
[8]
Pharmacokinetics of oxaliplatin (NSC 266046) alone and in combination with paclitaxel in cancer patients [J].
Liu, J ;
Kraut, E ;
Bender, J ;
Brooks, R ;
Balcerzak, S ;
Grever, M ;
Stanley, H ;
D'Ambrosio, S ;
Gibson-D'Ambrosio, R ;
Chan, KK .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2002, 49 (05) :367-374
[9]
Platinum determination in nutrient plants by inductively coupled plasma mass spectrometry with special respect to the hafnium oxide interference [J].
Lustig, S ;
Zang, S ;
Michalke, B ;
Schramel, P ;
Beck, W .
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1997, 357 (08) :1157-1163
[10]
CURRENT SAMPLE HANDLING METHODS FOR MEASUREMENT OF PLATINUM-DNA ADDUCTS IN LEUKOCYTES IN MAN LEAD TO DISCREPANT RESULTS IN DNA ADDUCT LEVELS AND DNA-REPAIR [J].
MA, J ;
VERWEIJ, J ;
PLANTING, AST ;
DEBOERDENNERT, M ;
VANINGEN, HE ;
VANDERBURG, MEL ;
STOTER, G ;
SCHELLENS, JHM .
BRITISH JOURNAL OF CANCER, 1995, 71 (03) :512-517